Outcomes in pediatric melanoma: Comparing prepubertal to adolescent pediatric patients

Annals of Surgery

Volumn 253, Issue 6, 2011, Pages 1211-1215

  Moore Olufemi, Stacey ^a,b   Herzog, Cynthia ^b   Warneke, Carla ^b   Gershenwald, Jerry E ^b   Mansfield, Paul ^b   Ross, Merrick ^b   Prieto, Victor ^b   Lally, Kevin P ^a,b   Hayes Jordan, Andrea ^a,b  

^a UNIVERSITY OF TEXAS   (United States)

^b UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; AGE; ARTICLE; CANCER PATIENT; CANCER SIZE; CANCER SURVIVAL; CHILD; CONTROLLED STUDY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MELANOMA; OVERALL SURVIVAL; PRESCHOOL CHILD; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SCHOOL CHILD; SENTINEL LYMPH NODE BIOPSY;

ADOLESCENT; AGE FACTORS; CHILD; CHILD, PRESCHOOL; DATABASES, FACTUAL; FEMALE; HUMANS; INFANT; LYMPH NODES; LYMPHATIC METASTASIS; MALE; MELANOMA; PROGNOSIS; RETROSPECTIVE STUDIES; SENTINEL LYMPH NODE BIOPSY; SKIN NEOPLASMS; SURVIVAL ANALYSIS; TREATMENT OUTCOME;

EID: 79957514570     PISSN: 00034932     EISSN: 15281140     Source Type: Journal    
DOI: 10.1097/SLA.0b013e318217e852     Document Type: Article

References (25)

1. Strouse JJ, Fears TR, Tucker MA, et al. Pediatric melanoma: risk factor and survival analysis of the surveillance, epidemiology and end results database. J Clin Oncol. 2005;23(21):4735-4741. (Pubitemid 46224077)
2. Ceballos PI, Ruiz-Maldonado R, Mihm MC Jr. Melanoma in children. N Engl J Med. 1995;332(10):656-662.
3. Ruiz-Maldonado R, Tamayo L, Laterza AM, et al. Giant pigmented nevi: clinical, histopathologic, and therapeutic considerations. J Pediatr. 1992;120(6):906-911.
4. Saenz NC, Saenz-Badillos J, Busam K, et al. Childhood melanoma survival. Cancer. 1999;85:750-754. (Pubitemid 29075297)
5. Daryanani D, Plukker JT, Nap RE, et al. Adolescent melanoma: risk factors and long term survival. Eur J Surg Oncol. 2006;32(2):218-223. (Pubitemid 43257127)
6. Ferrari A, Bono A, Baldi M, et al. Does melanoma behave differently in younger children than in adults? A retrospective study of 33 cases of childhood melanoma from a single institution. Pediatrics. 2005;115(3):649-654. (Pubitemid 43373024)
7. Livestro DP, Kaine EM, Michaelson JS, et al. Melanoma in the young: differences and similarities with adult melanoma: a case-matched controlled analysis. Cancer. 2007;110(3):614-624. (Pubitemid 47106151)
8. Abbassi V. Growth and normal puberty. Pediatrics. 1998;102(2 Pt 3): 507-511. (Pubitemid 28363703)
9. Punt CJ, Buyse M, Kohne CH, et al. Endpoints in adjuvant treatment trials: a systematic review of the literature in colon cancer and proposed definitions for future trials. J Natl Cancer Instit. 2007;99(13):998-1003. (Pubitemid 47232601)
10. Lange JR, Palis BE, Chang DC, et al. Melanoma in children and teenagers: an analysis of patients from the National Cancer Data Base. J Clin Oncol. 2007;25(11):1363-1368. (Pubitemid 46706883)
11. Sondak VK, Taylor JM, Sabel MS, et al. Mitotic rate and younger age are predictors of sentinel lymph node positivity: lessons learned from the generation of a probabilistic model. Ann Surg Oncol. 2004;11(3):247-258. (Pubitemid 40486764)
12. Balch CM, Soong SJ, Gershenwald JE, et al. Prognostic factors analysis of 17,600 melanoma patients: validation of the American Joint Committee on Cancer melanoma staging system. J Clin Oncol. 2001;19:3622-3634. (Pubitemid 32786275)
13. Morton DL, Wen DR, Wong JH, et al. Technical details of intraoperative lymphatic mapping for early stage melanoma. Arch Surg. 1992;127(4): 392-399.
14. Rousseau DL Jr, Ross MI, Johnson MM, et al. Revised American Joint Committee on Cancer staging criteria accurately predict sentinel lymph node positivity in clinically node-negative melanoma patients. Ann Surg Oncol. 2003;10(5):569-574. (Pubitemid 40486922)
15. Gershenwald JE, Thompson W, Mansfield PF, et al. Multi-institutional melanoma lymphatic mapping experience: the prognostic value of sentinel lymph node status in 612 stage I or II melanoma patients. J Clin Oncol. 1999;17(3):976-983. (Pubitemid 29109331)
16. Statius Muller MG, van Leeuwen PA, van Diest PJ, et al. No indication for performing sentinel node biopsy inmelanoma patientswith aBreslowthickness of less than 0.9 mm. Melanoma Res. 2001;11(3):303-307. (Pubitemid 32578818)
17. Matthew FK, Rebekah RW, Jeffrey LJ, et al. Thin melanomas predictive lethal characteristics from a 30-year clinical experience. Ann Surg. 2003;238: 528-537.
18. Lewis KG. Trends in pediatric melanoma mortality in the United States, 1968 through 2004. Dermatol Surg. 2008;34(2):152-159.
19. Hamre MR, Chuba P, Bakhshi S, et al. Cutaneous melanoma in childhood and adolescence. Pediatr Hematol Oncol. 2002;19(5):309-317. (Pubitemid 34633365)
20. Strouse JJ, Fears TR, Tucker MA, et al. Pediatric melanoma: risk factor and survival analysis of the surveillance, epidemiology and end results database. J Clin Oncol. 2005;23(21):4735-4741. (Pubitemid 46224077)
21. Rouhani P, Hu S, Kirsner RS. Melanoma in Hispanic and black Americans. Cancer Control. 2008;15(3):248-253.
22. Cress RD, Holly EA. Incidence of cutaneous melanoma among non-Hispanic whites, Hispanics, Asians, and blacks: an analysis of California cancer registry data, 1988-93. Cancer Causes Control. 1997;8(2):246-252. (Pubitemid 27170380)
23. Magro CM, Yaniv S, Mihm MC. The superficial atypical Spitz tumor and malignant melanoma of superficial spreading type arising in association with the superficial atypical Spitz tumor: a distinct form of dysplastic Spitzoid nevomelanocytic proliferation. J Am Acad Dermatol. 2009;60(5):814-823.
24. Da Forno PD, Fletcher A, Pringle JH, et al. Understanding spitzoid tumours: new insights from molecular pathology. Br J Dermatol. 2008;158(1):4-14. (Pubitemid 350221887)
25. Pol-Rodriquez M, Lee S, Silvers DN, et al. Influence of age on survival in childhood spitzoid melanomas. Cancer. 2007;109(8):1579-1583. (Pubitemid 46595694)